{"nctId":"NCT03093207","briefTitle":"Omega-3 Fatty Acids Plus Low-dose Aspirin Daily Supplementation in Surgical Therapy to Treat Aggressive Periodontitis","startDateStruct":{"date":"2017-05-15","type":"ACTUAL"},"conditions":["Residual Disease","Aggressive Periodontitis"],"count":34,"armGroups":[{"label":"Control group","type":"PLACEBO_COMPARATOR","interventionNames":["Procedure: Open flap debridement","Other: Placebo"]},{"label":"Test Group","type":"EXPERIMENTAL","interventionNames":["Procedure: Open flap debridement","Dietary Supplement: Omega-3 polyunsaturated fatty acids","Drug: Aspirin"]}],"interventions":[{"name":"Open flap debridement","otherNames":["Surgical therapy"]},{"name":"Placebo","otherNames":[]},{"name":"Omega-3 polyunsaturated fatty acids","otherNames":["Fish oil"]},{"name":"Aspirin","otherNames":["acetylsalicylic acid"]}],"eligibilityModule":{"eligibilityCriteria":"Inclusion criteria\n\n* Diagnosis of generalized aggressive periodontitis (Armitage, 1999; American Academy of Periodontology, 2015);\n* Have undergone a first approach for periodontal treatment (full-mouth ultrasonic debridement);\n* Present at least one residual pocket of probing depth ≥ 5 mm and bleeding on probe not located in furcation region;\n* Good general health;\n* Agree to participate in the study and sign the informed consent form (TCLE) after explaining the risks and benefits;\n\nExclusion Criteria\n\n* Systemic problems (cardiovascular alterations, blood dyscrasias, immunodeficiency - ASA III / IV / V) that contraindicate the periodontal procedure;\n* Have used antibiotics and anti-inflammatories in the last six months;\n* Smoke ≥ 10 cigarettes/day;\n* Pregnant or nursing;\n* Chronic use of medications that may alter the response of periodontal tissues;\n* Indication of antibiotic prophylaxis for dental procedures;\n* History of allergic reaction to acetylsalicylic acid, fish or seafood.","healthyVolunteers":true,"sex":"ALL","minimumAge":"18 Years","maximumAge":"35 Years","stdAges":["ADULT"]},"locations":{"multicenter":false},"periods":[],"outcomeMeasures":[{"type":"PRIMARY","title":"Clinical Attachment Level at Baseline, 3 Months and 6 Months","description":"Evaluate the difference between baseline and 6 months CAL measures. CAL: distance from bottom of sulcus/pocket to the cement-enamel junction (CEJ). The CEJ will be identified by careful probe on cervical area.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.5","spread":"0.25"},{"groupId":"OG001","value":"5.29","spread":"0.16"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.64","spread":"0.29"},{"groupId":"OG001","value":"4.73","spread":"0.28"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.64","spread":"0.22"},{"groupId":"OG001","value":"4.97","spread":"0.25"}]}]}]},{"type":"SECONDARY","title":"Probing Depth at Baseline, 3 Months and 6 Months","description":"Evaluate the difference between baseline and 6 months PB measures. PB: distance from the bottom of sulcus/pocket to gingival margin.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"5.17","spread":"0.2"},{"groupId":"OG001","value":"5.14","spread":"0.14"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4.08","spread":"0.21"},{"groupId":"OG001","value":"3.76","spread":"0.2"}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"4","spread":"0.15"},{"groupId":"OG001","value":"3.94","spread":"0.2"}]}]}]},{"type":"SECONDARY","title":"Percentage of Sites With Bleeding on Probe at Baseline, 3 Months and 6 Months","description":"Evaluate the difference between baseline and 6 months BoP measures. BoP: bleeding that is induced by gentle probing of the sulcus/pocket.","classes":[{"categories":[{"measurements":[{"groupId":"OG000","value":"100","spread":null},{"groupId":"OG001","value":"100","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"76.47","spread":null},{"groupId":"OG001","value":"100","spread":null}]}]},{"categories":[{"measurements":[{"groupId":"OG000","value":"64.7","spread":null},{"groupId":"OG001","value":"64.7","spread":null}]}]}]}],"adverseEventsModule":{"adverseEventsSummary":{"seriousAny":{"events":0,"n":17},"commonTop":[]}}}